The Significance of Bone Marrow Involvement in Aggressive Lymphomas: A Retrospective Comparison of Clinical Outcomes between Peripheral T Cell Lymphoma and Diffuse Large B Cell Lymphoma in China

Publisher： Karger

E-ISSN： 1421-9662|124|4|239-244

ISSN： 0001-5792

Source： Acta Haematologica, Vol.124, Iss.4, 2010-11, pp. : 239-244

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Incidence and Clinical Significance of Aberrant T-Cell Marker Expression on Diffuse Large B-Cell Lymphoma Cells

By  

Acta Haematologica, Vol. 130, Iss. 4, 2013-06 ,pp. : 230-237

Karger

Access to resources Recommend Favorite

Increased bone marrow FDG uptake at PET/CT is not a sufficient proof of bone marrow involvement in diffuse large B‐cell lymphoma

By  

AMERICAN JOURNAL OF HEMATOLOGY, Vol. 90, Iss. 9, 2015-09 ,pp. : E182-E182

John Wiley & Sons Inc

Access to resources Recommend Favorite

False‐negative FDG‐PET in histologically proven extensive large cell bone marrow involvement in diffuse large B‐cell lymphoma

By  

AMERICAN JOURNAL OF HEMATOLOGY, Vol. 90, Iss. 7, 2015-07 ,pp. : 681-681

John Wiley & Sons Inc

Access to resources Recommend Favorite

Synchronous biphenotypic Richter syndrome with Epstein–Barr virus‐positive nodal classical Hodgkin lymphoma and bone marrow diffuse large B‐cell lymphoma

By  

HISTOPATHOLOGY, Vol. 69, Iss. 4, 2016-10 ,pp. : 707-710

John Wiley & Sons Inc

Access to resources Recommend Favorite

Matched-Pair Analysis Comparing the Outcomes of T Cell/Histiocyte-Rich Large B Cell Lymphoma and Diffuse Large B Cell Lymphoma in Patients Treated with Rituximab-CHOP

By  

Acta Haematologica, Vol. 131, Iss. 3, 2013-10 ,pp. : 156-161

Karger

Access to resources Recommend Favorite